Archives des Highlights

Numerous metagenomics-based studies have associated gut microbiota dysbiosis with the progression and resistance to immunotherapy of intestinal and non-intestinal cancers. more

Gut microbiota dysbiosis contributes to the tumorigenic process, even in extra-intestinal malignancies

Jun 12, 2023 | Highlights, Microbiomes & cancer, Vaiomer original work

doi: 10.1158/2159-8290.CD-21-0999Numerous metagenomics-based studies have associated gut microbiota dysbiosis with the...

Vaiomer and Physiogenex are proud to announce the launch of the TRANSBIOTIC project, to develop and validate mouse models with human microbiomes for evaluating therapies targeting metabolic and inflammatory diseases. Thanks La Région Occitanie-Pyrénées-Méditerranée for its support !

Mouse models with human microbiome

Apr 27, 2023 | Highlights, News

Physiogenex and Vaiomer Launch the TRANSBIOTIC project: A New Collaborative Research Project on mouse models...

Yde et al., explored the changes in the microbiota composition and metabolite levels induced by pre- and/or probiotic in an HFD mouse model. More

Metabolism and obesity: influence of prebiotics, probiotics and symbiotics on microbiomes and liver health

Apr 24, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

doi: 10.1371/journal.pone.0260765Prebiotic, probiotic and symbiotic treatments affect intestinal and adipose tissue...

In this article, Ciocan and colleagues explored the blood microbiome and metabolome in patients with major depressive episodes (MDE) before and after treatment and compared them to healthy controls. More

Metabolism and Major Depression: Blood microbiome and metabolome exploration

Apr 24, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1503/jpn.200159 Response to antidepressant is associated with blood microbiome and metabolome of patients with...

Suppli et al., studied the microbiome in liver biopsies and blood from healthy lean and obese patients. More

Metabolism and Obesity: the liver microbiome & the development of NAFLD

Apr 6, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1016/j.jhepr.2021.100299 Changes in the liver microbiome as a risk factor for the development of NAFLD in...

Bernard et al. explored the relationship between oral microbiota composition & fat taste sensitivity in obese patients after Vertical Sleeve Gastrectomy. More

Metabolism and Obesity: Oral microbiota and fat taste sensitivity

Apr 5, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

doi: 10.3389/fnut.2022.1046454The relationship between oral microbiome and fat taste sensitivity in obese patients...

In 2022, Grasset and colleagues, explored the association between the gut-brain-beta cell glucagon-like peptide-1 (GLP-1)-dependent axis, the gut microbiota and the insulin sensitivity. More

Metabolism and T2D: GLP-1 sensitivity is linked with clock genes and ileal microbiome

Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1007/s00592-021-01790-yAssociation between the gut-brain-beta cell glucagon-like peptide-1(GLP-1)-dependent...

In 2021 Charpentier and colleagues showed that Liraglutide targets the gut microbiota and the glucolipid metabolism to regulate insulin secretion. More

Metabolism and T2D: liraglutide influences glucose metabolism and inflammation through gut microbiota

Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1007/s00592-020-01657-8Liraglutide targets the gut microbiota and the glucolipid metabolism to regulate...

Pomié and colleagues (2021) study the importance of the tight crosstalk between the intestinal immune system and the microbiota in metabolic disorders. More

Metabolism and Glycemic control: the crosstalk between intestinal microbiota and immune system

Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1007/s00592-021-01682-1 The tight crosstalk between the intestinal immune system and the microbiota in glucose...

Highlights Articles

Gut microbiota dysbiosis contributes to the tumorigenic process, even in extra-intestinal malignancies

Mouse models with human microbiome

Metabolism and obesity: influence of prebiotics, probiotics and symbiotics on microbiomes and liver health

Metabolism and Major Depression: Blood microbiome and metabolome exploration

Metabolism and Obesity: the liver microbiome & the development of NAFLD

Metabolism and Obesity: Oral microbiota and fat taste sensitivity

Metabolism and T2D: GLP-1 sensitivity is linked with clock genes and ileal microbiome

Metabolism and T2D: liraglutide influences glucose metabolism and inflammation through gut microbiota

Metabolism and Glycemic control: the crosstalk between intestinal microbiota and immune system

Research

Categorie

Archives

About Vaiomer :

Follow us !